President Clinton's Science Policies Draw Cheers, Jeers From Observers

After serving as chairman of the United States Senate subcommittee on science, technology, and space, Vice President Al Gore brought a technological and environmental bent to the White House. In addition to Gore's background, Clinton's 1992 pledges to build up the country's technology infrastructure, shift some R&D spending away from defense, and "significantly strengthen" the White House Office of Science and Technology Policy, may have raised expectations that a Clinton presidency would b

Written byThomas Durso
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

"There are people who, I am sure, were looking at the new administration and saying, 'Now we're going to get these large increases in the budgets of the agencies that support basic research,'" says Albert H. Teich, director for science policy at the Washington, D.C.-based American Association for the Advancement of Science (AAAS). "But the overall budget climate is constrained, and a president has to work within the constraints. Given the constraints, he has not done too badly, although I am concerned about the out years." Out-year budget projections are those extending more than two years ahead.

Like Republican rival Bob Dole, Clinton has not made science and technology a centerpiece of his campaign strategy. But in a faxed response to several questions posed by The Scientist, the campaign states that the president and administration officials "have and will continue to make public statements on science." However, it adds that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies